Welcome to Phoenix Rising!
Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of and finding treatments for complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia (FM), long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.
To register, simply click the Register button at the top right.
KIT mutations are linked to some mast cell illnesses.Exome testing is more common than full genome sequencing. The data files are alot smaller because youre only doing the exomes - and as a result alot cheaper too (exome tests 40 million positions and whole genome 3 billion positions so 75 times bigger)
It woukdnt be through medical testing but rather direct to consumer, much like one would order a 23 and me test - just more data than 23 and me ((which only sequences between 250,000 and 1 million positions depending on when a person tested. ). Exome testing sequencesas i mentioned above total about about 40 million so at least 40 times more data than 23 and me)
Especially interested at the moment in those who also appear to have a mast cell issue like MCAS.